Regulation_NN
of_IN
IL-6_NN
synthesis_NN
in_IN
human_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
by_IN
C3a_NN
and_CC
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
._.

The_DT
anaphylatoxin_NN
C3a_NN
has_VBZ
been_VBN
reported_VBN
to_TO
have_VB
immunomodulatory_JJ
effects_NNS
on_IN
a_DT
number_NN
of_IN
different_JJ
cell_NN
types_NNS
._.

In_IN
this_DT
study_NN
we_PRP
investigated_VBD
the_DT
effects_NNS
of_IN
C3a_NN
and_CC
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
on_IN
gene_NN
expression_NN
and_CC
protein_NN
secretion_NN
of_IN
IL-6_NN
in_IN
human_JJ
PBMCs_NNS
,_,
either_CC
alone_RB
or_CC
in_IN
combination_NN
with_IN
LPS_NN
or_CC
IL-1beta_NN
._.

C3a_NN
or_CC
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
alone_RB
exhibited_VBD
no_DT
effect_NN
on_IN
the_DT
expression_NN
or_CC
secretion_NN
of_IN
IL-6_NN
._.

However_RB
,_,
when_WRB
PBMC_NN
were_VBD
stimulated_VBN
with_IN
LPS_NN
or_CC
IL-1beta_NN
,_,
both_CC
C3a_NN
and_CC
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
were_VBD
found_VBN
to_TO
enhance_VB
IL-6_NN
release_NN
by_IN
PBMC_NN
in_IN
a_DT
dose-dependent_JJ
manner_NN
._.

Since_IN
C3a_NN
has_VBZ
been_VBN
shown_VBN
to_TO
induce_VB
PGE2_NN
production_NN
by_IN
monocytes_NNS
,_,
and_CC
PGE2_NN
has_VBZ
been_VBN
shown_VBN
to_TO
influence_VB
cytokine_NN
production_NN
,_,
we_PRP
investigated_VBD
the_DT
potential_JJ
role_NN
of_IN
PGE2_NN
in_IN
C3a-mediated_JJ
enhancement_NN
of_IN
LPS_NN
-_:
and_CC
IL-1beta-induced_JJ
IL-6_NN
production_NN
._.

Indomethacin_NN
blocked_VBD
PGE2_NN
release_NN
,_,
but_CC
had_VBD
no_DT
influence_NN
on_IN
the_DT
observed_VBN
effects_NNS
of_IN
C3a_NN
,_,
suggesting_VBG
that_IN
the_DT
effects_NNS
of_IN
C3a_NN
on_IN
IL-6_NN
production_NN
are_VBP
independent_JJ
of_IN
PGE2_NN
formation_NN
by_IN
monocytes_NNS
._.

Northern_NN
blot_NN
analysis_NN
showed_VBD
that_IN
C3a_NN
as_RB
well_RB
as_IN
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
enhanced_VBD
LPS-induced_JJ
mRNA_NN
levels_NNS
for_IN
IL-6_NN
._.

Pretreatment_NN
of_IN
PBMCs_NNS
with_IN
pertussis_NN
toxin_NN
blocked_VBD
the_DT
functions_NNS
of_IN
C3a_NN
and_CC
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
,_,
indicating_VBG
that_IN
the_DT
actions_NNS
of_IN
these_DT
two_CD
molecules_NNS
are_VBP
mediated_VBN
by_IN
a_DT
G_NN
protein-coupled_JJ
pathway_NN
._.

Furthermore_RB
,_,
we_PRP
investigated_VBD
the_DT
effects_NNS
of_IN
C3a_NN
and_CC
C3a_NN
-LRB-_-LRB-
desArg_NN
-RRB-_-RRB-
on_IN
induction_NN
of_IN
NF-kappaB_NN
and_CC
activating_VBG
protein-1_NN
binding_NN
._.

Both_DT
molecules_NNS
enhanced_VBD
LPS-induced_JJ
NF-kappaB_NN
and_CC
activating_VBG
protein-1_NN
binding_NN
activity_NN
._.

These_DT
results_NNS
demonstrate_VBP
the_DT
capacity_NN
of_IN
intact_JJ
C3a_NN
and_CC
its_PRP$
circulating_VBG
des-Arg_JJ
form_NN
to_TO
exert_VB
immunmodulatory_JJ
effects_NNS
in_FW
vitro_FW
._.

